IL17A and psoriasis: To address this question, we have employed the imiquimod (IMQ)-induced murine model of psoriasis, where topical application of IMQ stimulates a network of innate immune cells, such as DCs and IL-17-producing γδ TCR+ T cells, leading to psoriasiform skin inflammation10.